Gamfexine

Gamfexine is a synthetic pharmaceutical compound used primarily in the treatment of neurological disorders. It is classified as a neuroprotective agent and has been studied for its potential benefits in conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
Mechanism of Action[edit]
Gamfexine functions by modulating the activity of neurotransmitters in the central nervous system. It is believed to enhance the release of dopamine and serotonin, which are critical for maintaining neural plasticity and cognitive function. Additionally, Gamfexine exhibits antioxidant properties, reducing oxidative stress in neurons.
Pharmacokinetics[edit]
After oral administration, Gamfexine is rapidly absorbed in the gastrointestinal tract. It has a high bioavailability and is extensively metabolized in the liver. The primary route of excretion is through the renal system. The half-life of Gamfexine is approximately 12 hours, allowing for twice-daily dosing.
Clinical Uses[edit]
Gamfexine is prescribed for the management of symptoms associated with:
- Alzheimer's disease: It may help in slowing cognitive decline.
- Parkinson's disease: It can improve motor function and reduce tremors.
- Multiple sclerosis: It aids in reducing the frequency of relapses.
Side Effects[edit]
Common side effects of Gamfexine include:
Severe side effects are rare but may include allergic reactions and liver dysfunction.
Contraindications[edit]
Gamfexine is contraindicated in patients with:
- Known hypersensitivity to the drug
- Severe hepatic impairment
- Concurrent use of monoamine oxidase inhibitors (MAOIs)
Research and Development[edit]
Ongoing research is exploring the potential of Gamfexine in treating other neurodegenerative diseases and its role in neurogenesis. Clinical trials are also investigating its efficacy in combination with other neuroprotective agents.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian